Scientists from Arthritis Research Canada found a significant drop in all-cause mortality and major adverse cardiovascular events in people from the group who took glucagon-like peptide-1 receptor agonists.
In April 2023, community pharmacies reported 721 near-misses to ISMP Canada. It shared the most common problems—and suggested solutions—in a new bulletin.
Many chronic pain conditions actually involve a combination of all three of these phenomena—nociceptive, neuropathic and nociplastic pain—which adds to the difficulty of diagnosis and treatment.